Dupont Capital Management Corp Enanta Pharmaceuticals Inc Transaction History

Dupont Capital Management Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 27, 2020	SELL	$57.95 - $66.61 $282,042 - $324,190	-4,867 Closed	0 $0
Q3 2019 Oct 28, 2019	SELL	$60.08 - $88.17 $517,288 - $759,143	-8,610 Reduced 63.89%	4,867 $292,000
Q2 2019 Jul 30, 2019	BUY	$81.3 - $97.35 $95,446 - $114,288	1,174 Added 9.54%	13,477 $1.14 Million
Q2 2018 Jul 30, 2018	BUY	$81.85 - $120.51 $463,925 - $683,050	5,668 Added 85.43%	12,303 $1.43 Million
Q4 2017 Jan 31, 2018	SELL	$45.65 - $59.37 $438,148 - $569,833	-9,598 Reduced 59.13%	6,635 $389,000
Q3 2017 Oct 31, 2017	BUY	$37.91 - $46.8 $615,393 - $759,704	16,233	16,233 $760,000

108

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $109M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.